Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Aug. 22, 2022	Feb. 17, 2022
Business Acquisition [Line Items]
Goodwill	$ 17,905	$ 26,713
La Jolla Pharmaceutical Company
Business Acquisition [Line Items]
Cash and cash equivalents			$ 47,415
Short-term marketable securities			471
Accounts receivable			5,876
Inventory			66,200
Prepaid expenses			1,261
Other current assets			907
Property and equipment, net			13
Right-of-use assets			226
Goodwill			6,411
Intangible assets	151,000		151,000
Deferred tax assets			7,461
Other assets			710
Total assets acquired			287,951
Accounts payable			1,237
Deferred revenue, current			2,849
Other accrued liabilities			11,362
Other long-term liabilities			65,944
Total liabilities assumed			81,392
Total assets acquired, net			$ 206,559
Entasis Therapeutics Holdings Inc
Business Acquisition [Line Items]
Cash and cash equivalents				$ 23,070
Prepaid expenses				5,554
Other current assets				1,959
Property and equipment, net				185
Right-of-use assets				959
Goodwill				11,493
Intangible assets	$ 106,700			106,700
Other assets				302
Total assets acquired				150,222
Accounts payable				1,583
Accrued personnel-related expenses				1,058
Other current liabilities				5,096
Deferred tax liabilities				7,769
Total liabilities assumed				15,506
Total assets acquired, net				$ 134,716